E-ISSN 2636-834X
 

Review Article 


A challenging issue: Should medications be prescribed to pregnant and depressed women?

Nazan Aydın, Elif Oral, Mustafa Güleç.

Cited by (1)

Abstract
Women have higher prevalence rates of depression than men and they are particularly vulnerable to depression in childbearing years. The rates of depression can reach up to 20% of all women during pregnancy. Actually, physicians who treat women are likely to find themselves trying to choose the best option for protection of the mother and for the development of her child. Safety issues and negative birth outcomes are matters of concern with antidepressant use during pregnancy. Otherwise, untreated depression also has potential to cause health complications for both mother and infant. It is obvious that possible adverse effects of antidepressant use during pregnancy are more emphasized but adverse outcomes of untreated depression are underrated. Currently, studies exhibit conflicting results about antidepressant safety in pregnancy period so current data must be cautiously interpreted. The risks and benefits of both options must be taken into account in decision-making process with families.

Key words: Pregnancy, antidepressant safety, teratogenicity, untreated depression


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Nazan Aydın
Articles by Elif Oral
Articles by Mustafa Güleç
on Google
on Google Scholar


REFERENCES
1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698-709. [DOI via Crossref]    [Pubmed]   
2. Cohen L, Altshuler L. Pharmacologic management of psychiatric illness during pregnancy and the postpartum period. In: Dunner D, Rosenbaum J (editors). The Psychiatric Clinics of North America Annual of Drug Therapy. Philadelphia: WB Saunders Company, 1997: 21-60. [Pubmed]   
3. McBride W. Limb deformities associated with iminodibenzyl hydrochloride [letter]. Med J Aust 1972; 1: 492. [Pubmed]   
4. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotoninreuptake inhibitors in pregnancy and the risk of birth defects. National Birth Defects Prevention Study. N Engl J Med 2007; 28;356:2684-92. [DOI via Crossref]    [Pubmed]   
5. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. Firsttrimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007; 28;356:2675-83. [DOI via Crossref]    [Pubmed]   
6. Glaxo Smith Kline study EPIP083. GSK medicine: bupropion and paroxetine. Epidemiology study: preliminary report on bupropion in pregnancy and the occurrence of cardiovascular and major congenital malformation. Available:http://ctr.gsk.co.uk/summary/paroxetine/epip083.pdf).
7. Malm H, Artama M, Gissler M, Ritvanen A. Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies. Obstet Gynecol 2011;118:111-20. [DOI via Crossref]    [Pubmed]   
8. Källén BA, Otterblad Olausson P. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007; 79:301-8. [DOI via Crossref]    [Pubmed]   
9. Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65: 230-7. [DOI via Crossref]    [Pubmed]   
10. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn behaviour. Pediatrics 2004; 113:368-75. [DOI via Crossref]   
11. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 9;354:579-87. [DOI via Crossref]    [Pubmed]   
12. Jetter A. Pregnant Pause. Vogue 2009; 232:144-148.
13. Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142: 402-8. [DOI via Crossref]    [Pubmed]   
14. Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005; 115: 411-25. [DOI via Crossref]    [Pubmed]   
15. Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RC, Paul IA. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006; 31:47-57. [Pubmed]    [PMC Free Fulltext]   
16. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders. Arch Gen Psychiatry 2011 [Epub ahead of print]. [DOI via Crossref]   
17. Portnoi G, Chng LA, Karimi-Tabesh L, Koren G, Tan MP, Einarson A. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol 2003; 189:1374-7. [DOI via Crossref]   
18. McElhatton PR, Garbis HM, Eléfant E, Vial T, Bellemin B, Mastroiacovo P, Arnon J, Rodríguez-Pinilla E, Schaefer C, Pexieder T, Merlob P, Dal Verme S. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European network of teratology information services (ENTIS). Reprod Toxicol 1996; 10:285-94. [DOI via Crossref]   
19. Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996 May;153:592-606. [Pubmed]   
20. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. p. 319-20.
21. Kalra S, Einarson A. Prevalence, Clinical Course, and Management of Depression During Pregnancy. In: Psychiatric Disorders in Pregnancy and the Postpartum Principles and Treatment. Hendrick V, Ed, Humana Press, 2006 p.13-40. [DOI via Crossref]   
22. Pastuszak AL, Schick-Boschetto B, Zuber C, Feldkamp ML, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, Gardner A, Horn G, Koren G. 1993. Pregnancy Outcome following First-Trimester Exposure to Fluoxetine (Prozac). JAMA 269:2246-2248 [DOI via Crossref]    [Pubmed]   
23. Goldstein DJ. Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995; 15:417-20. [DOI via Crossref]    [Pubmed]   
24. Goldstein DJ, Corbin LA, Sundell KL. Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997; 89:713-8. [DOI via Crossref]   
25. Hendrick V, Smith LM, Suri R, Hwang S, Haynes D, Altshuler L. Birth outcomes following prenatal exposure to antidepressant medications. Am J Obstet Gynecol 2003; 188:812-5. [DOI via Crossref]    [Pubmed]   
26. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159:2055-61. [DOI via Crossref]    [Pubmed]   
27. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, Ormond K, Matsui D, Stein-Schechman AK, Cook L, Brochu J, Rieder M, Koren G. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998; 279:609-10. [DOI via Crossref]    [Pubmed]   
28. Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002; 156: 1129-32. [DOI via Crossref]    [Pubmed]   
29. Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002; 72: 184-91. [DOI via Crossref]    [Pubmed]   
30. Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, Mastroiacovo P, Addis A, Matsui D, Schuler L, Einarson TR, Koren G. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001; 158:1728-30. [DOI via Crossref]    [Pubmed]   
31. Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A, Shakir S, Einarson A. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005; 192:932-6. [DOI via Crossref]    [Pubmed]   
32. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889-95. [DOI via Crossref]    [Pubmed]   
33. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, Kulin N, Koren G. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 23:336: 258-62. [DOI via Crossref]    [Pubmed]   
34. Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry 1997;58:37-40. [Pubmed]   
35. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 1:295:499-507. [DOI via Crossref]    [Pubmed]   
36. Marcus SM, Flynn HA. Depression, antidepressant medication, and functioning outcomes among pregnant women. Int J Gynaecol Obstet 2008;100:248-51. [DOI via Crossref]    [Pubmed]   
37. Van den Hove DL, Steinbusch HW, Scheepens A, Van de Berg WD, Kooiman LA, Boosten BJ, Prickaerts J, Blanco CE. Prenatal stress and neonatal rat brain development. Neuroscience 2006; 137, 145-155. [DOI via Crossref]    [Pubmed]   
38. Flynn HA, Chermack ST. Prenatal alcohol use: the role of lifetime problems with alcohol, drugs, depression, and violence. J Stud Alcohol Drugs 2008; 69:500-9. [Pubmed]   
39. Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt) 2003;12: 373-80. [DOI via Crossref]    [Pubmed]   
40. Kelly RH, Russo J, Holt VL, Danielsen BH, Zatzick DF, Walker E, Katon W. Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstet Gynecol 2002; 100:297-304. [DOI via Crossref]   
41. Steer RA, Scholl TO, Hediger ML, Fischer RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 1992; 45:1093-9. [DOI via Crossref]   
42. Miller LJ. Clinical strategies for the use of psychotropic drugs during pregnancy. Psychiatr Med 1991;9: 275-98. [Pubmed]   
43. Zuckerman B, Bauchner H, Parker S, Cabral H. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 1990;11:190-4. [DOI via Crossref]    [Pubmed]   
44. Schmeelk KH, Granger DA, Susman EJ, Chrousos GP. Maternal depression and risk for postpartum complications: role of prenatal corticotropin-releasing hormone and interleukin-1 receptor antagonist. Behav Med 1999; 25:88-94. [DOI via Crossref]    [Pubmed]   
45. Bansil P, Kuklina EV, Meikle SF, Posner SF, Kourtis AP, Ellington SR, Jamieson DJ. Maternal and Fetal Outcomes Among Women with Depression. J Womens Health (Larchmt) 2010; 19:329-34. [DOI via Crossref]    [Pubmed]   
46. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 2000; 9:487-90. [DOI via Crossref]   
47. Hoffman S, Match MC. Depressive symptomatology during pregnancy: Evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol Bull 2000:535-43. [Pubmed]   
48. Lundy B, Jones N, Field T, Nearing G, Davalos M, Pietro P,Schanberg S, Kuhn C: Prenatal depression effects on neonates. Infant Behav Dev 1999; 22:119-129 [DOI via Crossref]   
49. Bonari L, Bennett H, Einarson A, Koren G. Risks of untreated depression during pregnancy. Can Fam Physician 2004; 50:37-9. [Pubmed]    [PMC Free Fulltext]   
50. Field T, Diego MA, Dieter J, Hernandez-Reif M, Schanberg S, Kuhn C, Yando R, & Bendell D. Depressed, withdrawn and intrusive mothers’ effects on their fetuses and neonates. Inf Behav and Dev 2001:27-39. [Pubmed]   
51. Chung TK, Lau TK, Yip AS, Chiu HF, Lee DT. Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 2001; 63:830-4. [DOI via Crossref]    [Pubmed]   
52. Lundy B, Field T. Newborns of mothers with depressive symptoms are less expressive. Infant Behav Dev 1996; 19; 419-424. [DOI via Crossref]   
53. Hay DF, Pawlby S, Waters CS, Sharp D. Antepartum and postpartum exposure to maternal depression: different effects on different adolescent outcomes. J Child Psychol Psychiatry 2008; 49(10):1079-88. [DOI via Crossref]    [Pubmed]   
54. Hay DF, Pawlby S, Waters CS, Perra O, Sharp D. Mothers’ antenatal depression and their children’s antisocial outcomes. Child Dev 2010; 81:149-65. [DOI via Crossref]    [Pubmed]   
55. Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ; STAR*D-Child Team. Remissions in maternal depression and child psychopathology, a STAR*D-Child Report. JAMA 2006; 22;295:1389-98. [DOI via Crossref]    [Pubmed]   
56. Weissman MM, Wickramaratne P, Nomura Y, Warner V, Pilowsky D, Verdeli H. Offspring of depressed parents: 20 years later. Am J Psychiatry 2006; 163:1001-8. [DOI via Crossref]    [Pubmed]   
57. Beck, CT. Revision of the postpartum depression predictors inventory. J Obstet Gynecol Neonatal Nurs 2002; 31: 394-402. [DOI via Crossref]   
58. TERIS.The Teratogen Information system. (www.depts.washington.edu/terisweb/teris/Preamble.htm)
59. Einarson A. Reproductive Mental Health– Motherrisk Update 2008. Risks/Safety of Psychotropic Medication use during Pregnancy. Can J Clin Pharmacol 2009;16, 1:1-67.

This Article Cited By the following articles

Psychiatrists' Attitudes Toward Psychopharmacologic Treatments During Pregnancy and Lactation Periods: A Survey Study
Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2015; 25(2): 100.

1
 
How to Cite this Article
Pubmed Style

Nazan Aydın, Elif Oral, Mustafa Güleç. A challenging issue: Should medications be prescribed to pregnant and depressed women?. PBS. 2011; 1(3): 118-125. doi:10.5455/jmood.20110902072926


Web Style

Nazan Aydın, Elif Oral, Mustafa Güleç. A challenging issue: Should medications be prescribed to pregnant and depressed women?. http://www.pbsciences.org/?mno=12081 [Access: September 27, 2021]. doi:10.5455/jmood.20110902072926


AMA (American Medical Association) Style

Nazan Aydın, Elif Oral, Mustafa Güleç. A challenging issue: Should medications be prescribed to pregnant and depressed women?. PBS. 2011; 1(3): 118-125. doi:10.5455/jmood.20110902072926



Vancouver/ICMJE Style

Nazan Aydın, Elif Oral, Mustafa Güleç. A challenging issue: Should medications be prescribed to pregnant and depressed women?. PBS. (2011), [cited September 27, 2021]; 1(3): 118-125. doi:10.5455/jmood.20110902072926



Harvard Style

Nazan Aydın, Elif Oral, Mustafa Güleç (2011) A challenging issue: Should medications be prescribed to pregnant and depressed women?. PBS, 1 (3), 118-125. doi:10.5455/jmood.20110902072926



Turabian Style

Nazan Aydın, Elif Oral, Mustafa Güleç. 2011. A challenging issue: Should medications be prescribed to pregnant and depressed women?. Psychiatry and Behavioral Sciences, 1 (3), 118-125. doi:10.5455/jmood.20110902072926



Chicago Style

Nazan Aydın, Elif Oral, Mustafa Güleç. "A challenging issue: Should medications be prescribed to pregnant and depressed women?." Psychiatry and Behavioral Sciences 1 (2011), 118-125. doi:10.5455/jmood.20110902072926



MLA (The Modern Language Association) Style

Nazan Aydın, Elif Oral, Mustafa Güleç. "A challenging issue: Should medications be prescribed to pregnant and depressed women?." Psychiatry and Behavioral Sciences 1.3 (2011), 118-125. Print. doi:10.5455/jmood.20110902072926



APA (American Psychological Association) Style

Nazan Aydın, Elif Oral, Mustafa Güleç (2011) A challenging issue: Should medications be prescribed to pregnant and depressed women?. Psychiatry and Behavioral Sciences, 1 (3), 118-125. doi:10.5455/jmood.20110902072926